feed,title,long_url,short_url
Benzinga,AstraZeneca-Daiichi Breast Cancer Drug Cuts Disease Progression Or Death Risk By Almost 50%,https://benzinga.com/general/biotech/22/06/27561454/astrazeneca-daiichi-breast-cancer-drug-cuts-disease-progression-or-death-risk-by-almost-50,https://bit.ly/3Mgdsek
